Pfizer To Buy King Pharma For $3.6 Billion In Cash

Pfizer to buy King Pharma for $3.6 billion in cash

NEW YORK (Reuters) - Pfizer Inc, the world's biggest drugmaker, has agreed to buy King Pharmaceuticals Inc for $3.6 billion, expanding its presence in the market for pain drugs.

Sections:  news   business   
RELATED ARTICLES
  • Microsoft may buy Barnes & Noble's Nook unit for $1 billion
    According to internal documents obtained by the website TechCrunch, Microsoft has offered $1 billion for the digital assets of Nook Media, Barnes & Noble's digital book venture. According to internal documents obtained by the website TechCrunch, Microsoft has offered $1 billion for the digital assets of Nook Media, Barnes & Noble's digital book venture. More
  • Bayer to pay $1.1B for California firm Conceptus
    Germany drug company Bayer AG says it intends to buy California-based Conceptus to expand its birth control offerings. Bayer said Monday it would launch a pupublicblic offer to pay $31.00 per share for all the stock in Conceptus, Inc. That means Bayer would pay $1.1 billion. More
  • Cancer Physicians Attack High Drug Costs
    More than 100 cancer specialists have banded together to persuade pharmaceutical companies to bring prices down, suggesting that the high prices for medicine needed to keep someone alive is profiteering. More
  • Swedish police find drugs on Bieber tour bus
    The latest chapter in Justin Bieber's European tour escapade was added Thursday when Swedish police said they had found drugs and a stun gun on the pop singer's bus. Lars Bystrom, spokesman for the Stockholm police, told The Associated Press a small amount of drugs and a stun gun were discovered during a search of the bus, which had been parked under the Globen concert venue in Stockholm, where Bieber was performing Wednesday. More
  • Why Did LinkedIn Acquire Pulse For $90 Million?
    Content has become a large initiative on LinkedIn’s web property, but it hasn’t translated as well to its mobile apps. More users are shifting to mobile, and as the Pulse team was mostly focused on mobile, they can contribute to LinkedIn’s content efforts specifically on mobile platforms. More
BING NEWS:
  • Better Buy: Pfizer vs. Viking Therapeutics
    Shares of Pfizer and Viking Therapeutics have been on markedly different trajectories over the prior three years. In this comparison, Pfizer scans as a safer choice for cautious investors, while ...
    04/23/2024 - 2:15 am | View Link
  • Is Pfizer Stock a Buy?
    Let's start by hearing from the bears about why the stock isn't a buy, and then look at the other side's argument. Under normal conditions, one might expect that a big pharma ... $58.5 billion ...
    04/14/2024 - 9:45 pm | View Link
  • This S&P 500 Dividend Stock Could Be the Best Bad-News Buy on the Market
    Admittedly, a quick look at Pfizer's stock chart screams "falling knife" a lot more than it does "dip." The big drugmaker's shares have plunged 35% over the last 12 months, while the S&P 500 has ...
    04/7/2024 - 10:48 pm | View Link
  • Prediction: Pfizer Won't Acquire Viking Therapeutics. Here's Why.
    Unsurprisingly, demand for Pfizer's COVID-19 products soared -- leading to record sales for the pharma giant ... reasons why I don't think Pfizer will buy Viking. First, the company just closed ...
    03/31/2024 - 2:31 am | View Link
  • Big Pharma Vs. Washington
    Moreover, Eliquis cost the U.S. government more than $12 billion in 2021 according to the ... No doubt, uncertainty abounds in the pharma and biotech space, but this is par for the course, while ...
    06/28/2023 - 12:32 pm | View Link
  • More

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News